{"gene":"DNAJA1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1999,"finding":"Hdj-2 (DNAJA1) and Hsc70 form complexes with nascent CFTR at the ER, with complex formation initiated when NBD1 emerges in the cytosol and diminishing after R-domain expression. In experiments with purified components, Hdj-2 and Hsc70 acted synergistically to suppress NBD1 aggregation, suggesting Hdj-2/Hsc70 facilitate early CFTR assembly including formation of an intramolecular NBD1-R-domain complex.","method":"Co-immunoprecipitation of CFTR translation intermediates with Hdj-2/Hsc70; in vitro aggregation suppression assay with purified components","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified components plus co-IP of endogenous complexes, multiple orthogonal methods in single study","pmids":["10075921"],"is_preprint":false},{"year":1999,"finding":"HDJ-2/HSDJ co-expression significantly suppresses polyglutamine-expanded androgen receptor (ARQ48) aggregate formation in HeLa cells; ARQ48 aggregates co-localize with and sequester HDJ-2/HSDJ, Hsp70, Hsp90, and proteasome PA700 caps but not 20S core particles.","method":"Transient transfection in HeLa cells, immunofluorescence, electron microscopy, co-localization studies","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression rescue experiment and co-localization, single lab, two orthogonal methods","pmids":["10196362"],"is_preprint":false},{"year":1997,"finding":"HDJ-2/HSDJ overexpression corrects aberrant subnuclear trafficking of a glucocorticoid receptor zinc finger mutant (R496) and restores its transactivation and transrepression activity, demonstrating that the Hsp70/DnaJ chaperone system can act in the nucleus to refold mislocalized/misfolded receptors.","method":"Transient transfection in COS-1 cells, immunofluorescence co-localization, transactivation/transrepression reporter assays","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression rescue with functional readouts, single lab, two orthogonal methods","pmids":["9168467"],"is_preprint":false},{"year":1998,"finding":"HDJ-2 (DNAJA1) is farnesylated but not glycosylated, is ubiquitously expressed, localizes throughout the cytoplasm and around the nuclear membrane under basal conditions, and migrates to the Golgi, nucleolus, and nuclear membrane upon heat shock.","method":"Immunohistochemistry with polyclonal and monoclonal antibodies, metabolic labeling to determine farnesylation, Western and Northern blot analysis","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical characterization of PTM (farnesylation) plus localization by immunostaining, single lab, two orthogonal methods","pmids":["9839446"],"is_preprint":false},{"year":2006,"finding":"Irradiation causes HDJ-2 to migrate from the cytoplasm to the nucleus; this migration is inhibited by farnesyltransferase inhibitor R115777 pre-treatment. Genetic inhibition of HDJ-2 increases radiosensitivity, while overexpression confers radioresistance in glioblastoma cells.","method":"Immunofluorescence microscopy for HDJ-2 localization, siRNA knockdown and overexpression with clonogenic survival assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence, loss- and gain-of-function with survival readout, single lab","pmids":["16818651"],"is_preprint":false},{"year":2016,"finding":"DNAJA1 stabilizes misfolded/conformational mutant p53 by direct interaction, preventing CHIP ubiquitin ligase-mediated ubiquitylation and proteasomal degradation. Knockdown of DNAJA1 induces CHIP-mediated nuclear export, ubiquitylation, and degradation of mutant p53. Mevalonate-5-phosphate (reduced by statins) is required for this DNAJA1-mutp53 protective interaction.","method":"siRNA knockdown, co-immunoprecipitation, high-throughput statin screening, overexpression rescue experiments in cancer cell lines","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, knockdown and overexpression rescue, pathway epistasis with mevalonate pathway, replicated across multiple methods and cell lines","pmids":["27775703"],"is_preprint":false},{"year":2019,"finding":"Farnesylation of DNAJA1 at its C-terminal CAAX motif is required for its ability to bind and stabilize mutant p53. A C394S CAAX-box mutation abolishes DNAJA1 farnesylation and eliminates its capacity to maintain mutant p53 stabilization. Farnesyl pyrophosphate supplementation rescues atorvastatin-induced mutant p53 degradation.","method":"Site-directed mutagenesis of DNAJA1 CAAX box, co-immunoprecipitation with anti-DNAJA1/p53 antibodies, farnesyltransferase inhibitor (tipifarnib) treatment, FTase gene knockdown, genetically engineered mouse model","journal":"Molecular carcinogenesis","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of functional residue with co-IP validation, pharmacological and genetic inhibition of farnesylation, in vivo mouse model, multiple orthogonal methods","pmids":["31397499"],"is_preprint":false},{"year":2014,"finding":"DNAJA1 is a substrate of HDAC6 deacetylase; HDAC6 interacts with DNAJA1 and negatively regulates its acetylation levels. HDAC6-mediated deacetylation modulates the interaction between Hsc70 and DNAJA1.","method":"Quantitative proteomics of lysine acetylation in HDAC6 knockout mouse liver, co-immunoprecipitation validation, functional interaction assays in cultured cells","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative proteomics plus co-IP validation, functional consequence on Hsc70-DNAJA1 interaction demonstrated, single lab","pmids":["25311840"],"is_preprint":false},{"year":2014,"finding":"DnaJA1 associates with the PB2 and PA subunits of influenza A virus RNA polymerase and enhances viral RNA synthesis in vivo and in vitro. Upon influenza infection, DnaJA1 translocates from cytoplasm to nucleus along with PB1-PA nuclear import. The enhancement of viral RNA synthesis is dependent on DnaJA1's C-terminal substrate-binding domain, not the J-domain (Hsp70-interaction domain).","method":"Co-immunoprecipitation, in vitro RNA synthesis assay, immunofluorescence for nuclear translocation, domain deletion/mutation analysis","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro RNA synthesis assay plus co-IP and domain mutagenesis, multiple orthogonal methods, single lab","pmids":["25253355"],"is_preprint":false},{"year":2012,"finding":"DnaJA1 overexpression promotes tau clearance via ubiquitin-dependent mechanisms, while DnaJA1 knockdown facilitates tau accumulation. DnaJA1-mediated tau reduction requires lysines known to be poly-ubiquitinated in Alzheimer's brain. Hsp70 co-induction attenuates DnaJA1-driven tau clearance. In vivo, DnaJA1 and tau levels are inversely correlated.","method":"Overexpression and siRNA knockdown in cell lines, in vivo correlation studies, ubiquitination site mutant analysis","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function with mechanistic follow-up (ubiquitin-dependence), in vivo correlation, single lab, multiple methods","pmids":["22343013"],"is_preprint":false},{"year":2011,"finding":"DnaJa1 (but not the paralog DnaJa2) specifically stabilizes activation-induced deaminase (AID), maintaining its protein levels and biological activity. DnaJa1 depletion reduces AID levels, stability, and isotype switching in B cells. DnaJa1-deficient mice show compromised immunization responses and reduced AID protein and isotype switching by ~50%. DnaJa1 farnesylation is required for AID stabilization.","method":"Overexpression and siRNA knockdown in cell lines, DnaJa1 knockout mice, farnesyltransferase inhibitor treatment, isotype-switching assays, in vitro interaction studies","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model, loss- and gain-of-function, pharmacological farnesylation inhibition, functional isotype-switching readout, replicated across multiple systems","pmids":["22085931"],"is_preprint":false},{"year":2014,"finding":"NMR solution structure of the J-domain of DNAJA1 was solved, identifying a potential DnaK (Hsp70) binding site that overlaps with a predicted inhibitory binding site, suggesting DNAJA1 activity is regulated at this interface. DNAJA1 overexpression suppresses c-Jun hyperphosphorylation and the JNK pathway in pancreatic cancer cells.","method":"NMR structure determination, ligand affinity screen, bioinformatics analysis, overexpression in cell lines with JNK pathway readouts","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR structure with bioinformatics and functional overexpression data, single lab, multiple methods but limited mechanistic depth for JNK finding","pmids":["24512202"],"is_preprint":false},{"year":2003,"finding":"Two isoforms of HSJ2 (DNAJA1) arise from alternative splicing: HSJ2a (326 aa) localizes to the nucleus when fused to GFP in HeLa cells, while HSJ2b (241 aa, lacking a putative NLS) distributes throughout the cell.","method":"GFP-fusion protein expression in HeLa cells, fluorescence microscopy","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct live-cell localization by GFP imaging, single lab, single method, but clear functional consequence of alternative splicing on localization","pmids":["12974469"],"is_preprint":false},{"year":2016,"finding":"DNAJA1 is identified as a novel interacting partner and substrate of transglutaminase 2 (TG2). The catalytic core domain of TG2 is essential for interaction. DNAJA1 interacts with the open (active) conformation of TG2 and regulates its transamidation activity in vitro and in situ. DNAJA1 itself serves as a glutamine-donor substrate of TG2.","method":"GST pull-down assay, mass spectrometry, ELISA, surface plasmon resonance, domain variant interaction studies, in vitro and in situ transamidation activity assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal binding assays (pulldown, SPR, ELISA) plus enzymatic activity measurement, single lab but rigorous","pmids":["27551108"],"is_preprint":false},{"year":2019,"finding":"DNAJA1 physically interacts with PIWI protein SMEDWI-2 in planarian S. mediterranea (validated by yeast two-hybrid and co-IP). DNAJA1 is required for stability of SMEDWI-1 and SMEDWI-2 proteins. Human DNAJA1 similarly binds PIWIL1 and is required for PIWIL1 stability in human gastric cancer cells, demonstrating evolutionary conservation of this chaperone-client relationship.","method":"Yeast two-hybrid screen, co-immunoprecipitation, RNAi knockdown, protein stability assays in planarian and human cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus knockdown with stability readout, validated in both planarian and human cells, single lab","pmids":["31076507"],"is_preprint":false},{"year":2019,"finding":"DNAJA1 is activated transcriptionally by E2F1 and stabilizes CDC45 protein, thereby promoting cell cycle progression in colorectal cancer cells. KNK437 treatment sharply reduces DNAJA1 levels and reverses CDC45 stabilization.","method":"siRNA knockdown, overexpression, in vitro and in vivo tumor growth assays, ChIP/reporter assays for E2F1-DNAJA1 transcriptional regulation, western blot for CDC45 protein levels","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined molecular mechanism (E2F1→DNAJA1→CDC45), single lab, multiple cell and animal model validations","pmids":["31477839"],"is_preprint":false},{"year":2020,"finding":"In silico homology modeling and site-directed mutagenesis identified a druggable interacting pocket in the DNAJA1 glycine/phenylalanine-rich region critical for interaction with mutant p53 R175H. Mutations in this pocket disrupted DNAJA1-mutp53 interaction and reduced mutp53 stability.","method":"3D homology modeling, site-directed mutagenesis, co-immunoprecipitation, virtual drug screening, in vitro and in vivo cancer growth assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis of interaction interface validated by co-IP with functional consequence, plus computational modeling, single lab","pmids":["33208462"],"is_preprint":false},{"year":2021,"finding":"DNAJA1 selectively binds to unfolded (conformational) mutant p53 but not DNA-contact mutant p53, wild-type p53, or p53-null. DNAJA1 knockdown decreases mutp53 levels, reduces filopodia/lamellipodia formation, and decreases active CDC42/RAC1 in HNSCC cells in a mutp53-dependent manner. DNAJA1 knockdown inhibits primary tumor growth and metastasis to lymph nodes and lungs.","method":"siRNA knockdown, co-immunoprecipitation, in vitro migration assays, Rho GTPase activity assays, in vivo xenograft metastasis models","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP with selectivity for conformational mutp53, loss-of-function with mechanistic pathway (CDC42/RAC1), in vivo metastasis model, multiple orthogonal methods","pmids":["34183772"],"is_preprint":false},{"year":2021,"finding":"Cereblon (CRBN), a substrate-recruiting subunit of cullin4-RING-E3-ligase, targets DNAJA1 (DJ2) and Hsp70 for ubiquitin-mediated degradation. CRBN knockout enhances DJ2 chaperone activity, reducing tau phosphorylation and aggregation, improving tau-microtubule association, and reducing accumulation of pathologic tau. DJ2 overexpression prevents tau aggregation induced by okadaic acid and heparin.","method":"Co-immunoprecipitation, CRBN knockout mouse model, tau aggregation assays, kinase activity assays (GSK3, ERK, p38), in vivo tau pathology assessment","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus knockout mouse model with functional readouts, single lab, multiple methods","pmids":["33972400"],"is_preprint":false},{"year":2023,"finding":"Zinc binding is required for DNAJA1 structural stability and chaperone function (protection of client proteins from aggregation). Zinc removal destabilizes DNAJA1 and impairs its chaperone activity; reintroduction of zinc restores native properties. Copper can partially substitute for zinc in restoring DNAJA1 function.","method":"In vitro chaperone activity assay (aggregation suppression), metal chelation and reconstitution, yeast complementation assay (ydj1-deletion strain), biophysical stability measurements","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution and yeast complementation, single lab, multiple orthogonal methods","pmids":["37244380"],"is_preprint":false},{"year":2020,"finding":"DNAJA1 knockout results in a 4-fold decrease in polyglutamine74-huntingtin (polyQ74htt) aggregation in HEK293 cells, opposite to the 5-fold increase seen with DNAJB6 knockout, demonstrating that DNAJA1 and DNAJB6 modulate polyQ aggregation in opposing manners.","method":"CRISPR/Cas9 knockout in HEK293 cells, fluorescence microscopy, filter trap assay, cell viability assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR knockout with two orthogonal readouts (microscopy + FTA), single lab","pmids":["32424160"],"is_preprint":false},{"year":2024,"finding":"DNAJA1 knockout significantly reduces protein polyubiquitination in mouse testis and results in complete male infertility with spermatogenesis defects. DNAJA1 is co-localized with residual bodies in elongating spermatids, and its expression peaks during postnatal spermatogenesis.","method":"DNAJA1 knockout mice, Western blotting, immunofluorescence, fertility assays","journal":"Reproductive toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse model with defined cellular phenotype (infertility, reduced polyubiquitination), single lab, two orthogonal methods","pmids":["39208916"],"is_preprint":false},{"year":2025,"finding":"PSMD9 directly interacts with DNAJA1 via an EXKK motif. This interaction was confirmed by in vitro binding assays with purified proteins, and mutations in DNAJA1 disrupting the EXKK motif abolished binding. PSMD9 depletion led to elevated mitochondrial membrane potential, linking the PSMD9-DNAJA1 interaction to mitochondrial regulation. Proteasomal inhibition enhanced the PSMD9-DNAJA1 interaction and correlated with increased DNAJA1 stability.","method":"Mass spectrometry, in vitro binding assays with purified proteins, site-directed mutagenesis of DNAJA1, co-immunoprecipitation from MCF7 cells, mitochondrial membrane potential measurement","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding assay plus co-IP with mutagenesis validation and functional mitochondrial readout, single lab, multiple orthogonal methods","pmids":["40412052"],"is_preprint":false},{"year":2026,"finding":"YOD1 deubiquitinase stabilizes DNAJA1 through deubiquitination, identified by molecular docking, co-immunoprecipitation, and protein stability assays. Stabilized DNAJA1 binds HSP70 to activate the mitochondrial unfolded protein response (UPRmt), reducing neuronal apoptosis and mitochondrial damage after subarachnoid hemorrhage.","method":"Molecular docking, co-immunoprecipitation, protein stability assays, YOD1 overexpression in vivo and in vitro models of SAH, mitochondrial function assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus protein stability and functional rescue assays, in vivo model, single lab, multiple methods","pmids":["42103167"],"is_preprint":false},{"year":2022,"finding":"The first 107 amino acid NMR structure of DNAJA1 (J-domain and linker region) was solved, identifying protein and ligand binding sites. Pull-down assays identified 8 novel protein binding partners. NMR and isothermal titration calorimetry confirmed 5 drug-like compounds binding to two distinct sites on DNAJA1.","method":"NMR structure determination, virtual drug screening, NMR binding assays, isothermal titration calorimetry, pull-down assay with mass spectrometry","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR structure with ITC binding validation, multiple orthogonal methods, single lab","pmids":["36291603"],"is_preprint":false},{"year":2022,"finding":"A compound A11 (analog of virtual-screen hit 7-3) reduces DNAJA1 and conformational mutant p53 levels by binding to the J-domain of DNAJA1 at residues Y7, K44, and Q47. Alanine mutations at these positions prevent A11 binding and render cells insensitive to A11-mediated DNAJA1 and mutp53 depletion and inhibition of cell migration.","method":"In silico docking of ~10 million compounds, site-directed mutagenesis, cell-based assays for DNAJA1 and mutp53 levels, migration assays, filopodia formation assays","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis of binding residues validated by functional rescue, combined with virtual screen and cell-based assays, single lab","pmids":["36316326"],"is_preprint":false},{"year":2000,"finding":"HDJ-2/HSDJ overexpression increased polyglutamine huntingtin exon 1 inclusion formation in COS-7 cells (a pro-aggregation effect), while having no significant effect on inclusion formation in PC12 and SH-SY5Y cells, demonstrating a cell-type-dependent and potentially aggregation-promoting role for DNAJA1 with mutant huntingtin.","method":"Transient transfection in COS-7, PC12, and SH-SY5Y cells, fluorescence microscopy for inclusion counting","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method, cell-type variable results without mechanistic explanation","pmids":["10717003"],"is_preprint":false},{"year":2022,"finding":"In yeast and Drosophila models of Alzheimer's disease, the DNAJA1 ortholog Ydj1 physically interacts with amyloid-beta (Abeta) peptides, facilitates Abeta aggregation into small oligomers, and promotes their translocation to mitochondria. Deletion or downregulation of this chaperone protected from Abeta-mediated toxicity.","method":"Genetic screen in yeast, molecular interaction assays, Drosophila AD model with knockdown, mitochondrial fractionation","journal":"Cell stress","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic screen plus physical interaction and organellar localization studies in two model organisms, single lab","pmids":["36448030"],"is_preprint":false},{"year":2024,"finding":"DNAJA1 knockout alleviates heat-stroke-induced endothelial barrier disruption by suppressing the MLCK-MLC signaling pathway and protecting cell junction protein expression (ZO-1, claudin-5, JAM-A, occludin). Proteomic analysis identified 102 proteins activated by heat stroke and inhibited by DNAJA1 knockout, enriched in calcium signaling and vascular-barrier regulation pathways.","method":"DNAJA1 knockout cells (lentivirus-mediated) and mice, transepithelial electrical resistance, FITC-Dextran permeability, flow cytometry, western blotting, quantitative proteomics, in vivo heat stroke mouse model","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined pathway (MLCK-MLC) and in vivo validation, single lab, multiple orthogonal methods","pmids":["38551163"],"is_preprint":false}],"current_model":"DNAJA1 is a farnesylated Hsp40/DnaJ co-chaperone that recruits and stimulates Hsc70/Hsp70 ATPase activity via its J-domain, but also acts independently through its C-terminal substrate-binding domain (e.g., to enhance influenza RNA polymerase activity); it stabilizes client proteins including misfolded/conformational mutant p53, AID, PIWI proteins, CDC45, and tau by preventing their proteasomal degradation—a function requiring DNAJA1 farnesylation and regulated by HDAC6-mediated deacetylation, CRBN-mediated ubiquitination, and YOD1-mediated deubiquitination—while its zinc-binding is required for structural integrity and chaperone activity, and its subcellular localization (cytoplasm at rest; nucleus or Golgi upon stress or viral infection) is tightly linked to its diverse cellular functions in proteostasis, cell cycle regulation, DNA damage response, spermatogenesis, and mitochondrial homeostasis."},"narrative":{"mechanistic_narrative":"DNAJA1 (Hdj-2/HSDJ) is a farnesylated Hsp40/DnaJ co-chaperone that partners with Hsc70/Hsp70 to govern protein quality control across folding, assembly, and stability decisions [PMID:10075921, PMID:9839446]. Through its J-domain it recruits and is regulated at the Hsp70 interface, a surface defined structurally by NMR that overlaps a predicted inhibitory site [PMID:24512202, PMID:36291603], while its zinc-binding architecture is required for structural integrity and aggregation-suppressing chaperone activity, with copper able to partially substitute for zinc [PMID:37244380]. Acting with Hsc70, DNAJA1 suppresses aggregation of folding-challenged clients such as nascent CFTR NBD1 and polyglutamine-expanded androgen receptor, and can refold mislocalized nuclear receptors [PMID:10075921, PMID:10196362, PMID:9168467]. A central, recurring activity is the stabilization of specific client proteins against proteasomal degradation: it selectively binds conformational (not DNA-contact or wild-type) mutant p53 to block CHIP-mediated ubiquitylation and degradation, sustaining oncogenic migration, filopodia formation, and metastasis via CDC42/RAC1 [PMID:27775703, PMID:33208462, PMID:34183772], and it likewise stabilizes activation-induced deaminase (AID) to support antibody isotype switching [PMID:22085931], PIWI proteins including PIWIL1 [PMID:31076507], and E2F1-induced CDC45 to drive cell-cycle progression [PMID:31477839]. Stabilization of mutant p53 and AID requires DNAJA1 farnesylation at its C-terminal CAAX motif, linking its function to the mevalonate pathway and rendering it sensitive to statins and farnesyltransferase inhibitors [PMID:27775703, PMID:31397499, PMID:22085931]. DNAJA1 abundance and activity are themselves controlled post-translationally by HDAC6-mediated deacetylation that tunes Hsc70 binding [PMID:25311840], CRBN-mediated ubiquitin-dependent degradation [PMID:33972400], and YOD1-mediated deubiquitination [PMID:42103167]. Its handling of aggregation-prone neuronal substrates is context-dependent — it promotes ubiquitin-dependent tau clearance [PMID:22343013, PMID:33972400] yet can favor aggregation of polyglutamine huntingtin and amyloid-beta [PMID:32424160, PMID:36448030]. DNAJA1 relocalizes from the cytoplasm to the nucleus, nucleolus, or Golgi upon heat shock, irradiation, or influenza infection, where it independently binds the PB2/PA polymerase subunits to enhance viral RNA synthesis through its C-terminal substrate-binding domain rather than its J-domain [PMID:9839446, PMID:16818651, PMID:25253355]. At the organismal level DNAJA1 supports radioresistance [PMID:16818651], spermatogenesis and male fertility [PMID:39208916], and mitochondrial homeostasis, including activation of the mitochondrial unfolded protein response [PMID:40412052, PMID:42103167].","teleology":[{"year":1997,"claim":"Established that the Hsp70/DnaJ system can act in the nucleus, not just cytoplasm, by showing DNAJA1 overexpression rescues a misfolded glucocorticoid receptor mutant's trafficking and transcriptional function.","evidence":"Overexpression rescue with immunofluorescence and reporter assays in COS-1 cells","pmids":["9168467"],"confidence":"Medium","gaps":["Direct binding to the receptor not demonstrated","Endogenous-level relevance not tested"]},{"year":1998,"claim":"Defined DNAJA1's basal physical properties and stress behavior — it is farnesylated, ubiquitously expressed, and redistributes to Golgi/nucleolus/nuclear membrane on heat shock — framing localization as a regulated feature.","evidence":"Metabolic labeling for farnesylation plus immunostaining and blotting","pmids":["9839446"],"confidence":"Medium","gaps":["Functional role of farnesylation not yet defined","Mechanism of stress relocalization unknown"]},{"year":1999,"claim":"Showed DNAJA1 works synergistically with Hsc70 on a physiological folding client (nascent CFTR), suppressing NBD1 aggregation during co-translational assembly, establishing its general aggregation-suppression activity.","evidence":"Co-IP of CFTR translation intermediates plus in vitro aggregation assay with purified components","pmids":["10075921"],"confidence":"High","gaps":["ATPase stimulation kinetics not quantified","In vivo CFTR maturation consequence not measured"]},{"year":1999,"claim":"Extended chaperone activity to disease-relevant aggregates, showing DNAJA1 suppresses polyglutamine androgen receptor aggregation and is sequestered into inclusions with Hsp70/Hsp90 and proteasome caps.","evidence":"Transfection, immunofluorescence, and EM co-localization in HeLa cells","pmids":["10196362"],"confidence":"Medium","gaps":["Direct vs indirect suppression not distinguished","Single overexpression system"]},{"year":2000,"claim":"Revealed that DNAJA1's effect on aggregation is substrate- and cell-type-dependent, sometimes promoting rather than suppressing polyglutamine huntingtin inclusions.","evidence":"Transfection and inclusion counting across COS-7, PC12, SH-SY5Y cells","pmids":["10717003"],"confidence":"Low","gaps":["Single method without mechanistic explanation","Cell-type variability unexplained"]},{"year":2003,"claim":"Linked alternative splicing to subcellular targeting, showing an NLS-containing isoform localizes to the nucleus while the shorter isoform distributes diffusely.","evidence":"GFP-fusion imaging in HeLa cells","pmids":["12974469"],"confidence":"Medium","gaps":["Functional differences between isoforms not characterized","Endogenous isoform abundance unknown"]},{"year":2006,"claim":"Connected stress-induced nuclear migration to a phenotype, showing irradiation drives farnesylation-dependent nuclear translocation of DNAJA1 and that DNAJA1 levels set radiosensitivity.","evidence":"Immunofluorescence, FTase inhibitor, siRNA/overexpression with clonogenic survival in glioblastoma cells","pmids":["16818651"],"confidence":"Medium","gaps":["Nuclear DNAJA1 substrates after irradiation unknown","Mechanism linking DNAJA1 to DNA damage response undefined"]},{"year":2011,"claim":"Identified the first endogenous client whose stability depends on DNAJA1 — AID — establishing paralog-specific, farnesylation-dependent client stabilization with an immune phenotype.","evidence":"Knockdown/overexpression, knockout mice, FTase inhibitor, isotype-switching assays","pmids":["22085931"],"confidence":"High","gaps":["Whether stabilization is Hsp70-dependent not resolved","Direct AID-binding interface not mapped"]},{"year":2012,"claim":"Showed DNAJA1 promotes ubiquitin-dependent clearance of tau, positioning it in neurodegenerative proteostasis.","evidence":"Overexpression/knockdown, ubiquitination-site mutants, in vivo correlation","pmids":["22343013"],"confidence":"Medium","gaps":["E3 ligase mediating tau clearance not identified","Relationship to Hsp70 co-induction antagonism unexplained"]},{"year":2014,"claim":"Defined post-translational and structural regulation of DNAJA1 — HDAC6 deacetylation tunes Hsc70 binding, and NMR mapped a J-domain Hsp70/inhibitory interface — and linked DNAJA1 to JNK signaling.","evidence":"Acetylome proteomics and co-IP (HDAC6); NMR structure and JNK readouts in cancer cells","pmids":["25311840","24512202"],"confidence":"Medium","gaps":["Acetylation sites controlling activity not pinpointed","Mechanism of JNK suppression undefined"]},{"year":2014,"claim":"Established a J-domain-independent function, showing DNAJA1 binds influenza PB2/PA, translocates to the nucleus on infection, and enhances viral RNA synthesis via its C-terminal substrate-binding domain.","evidence":"Co-IP, in vitro RNA synthesis assay, domain mutagenesis, immunofluorescence","pmids":["25253355"],"confidence":"High","gaps":["Whether enhancement reflects chaperoning of polymerase folding vs direct effect unclear","Hsp70 involvement not tested"]},{"year":2016,"claim":"Defined DNAJA1's most-studied oncogenic client: it directly binds and stabilizes conformational mutant p53 by blocking CHIP-mediated degradation, a function dependent on the mevalonate pathway.","evidence":"Reciprocal co-IP, knockdown/rescue, statin screen in cancer lines","pmids":["27775703"],"confidence":"High","gaps":["Precise binding interface not yet mapped at this stage","Generality across mutp53 alleles untested here"]},{"year":2016,"claim":"Identified DNAJA1 as an interactor, regulator, and glutamine-donor substrate of transglutaminase 2, coupling it to TG2 conformational/activity control.","evidence":"GST pull-down, MS, ELISA, SPR, transamidation assays","pmids":["27551108"],"confidence":"High","gaps":["Cellular consequence of TG2 modification of DNAJA1 unknown","Physiological context of this interaction undefined"]},{"year":2019,"claim":"Mechanistically tied DNAJA1's client-stabilizing function to its lipid modification, showing CAAX-motif farnesylation is required to bind and protect mutant p53.","evidence":"CAAX mutagenesis, co-IP, FTase inhibitor and knockdown, mouse model","pmids":["31397499"],"confidence":"High","gaps":["How farnesylation enables client binding mechanistically unclear","Membrane vs soluble pool contributions unresolved"]},{"year":2019,"claim":"Expanded the client repertoire to germline and cell-cycle proteins — DNAJA1 stabilizes conserved PIWI proteins (PIWIL1) and E2F1-induced CDC45 to drive proliferation.","evidence":"Yeast two-hybrid, co-IP, knockdown, stability assays in planarian/human cells (PIWI); ChIP/reporter and stability assays in colorectal cells (CDC45)","pmids":["31076507","31477839"],"confidence":"Medium","gaps":["Whether stabilization is direct chaperoning or indirect not fully resolved","Hsp70 dependence not established for these clients"]},{"year":2020,"claim":"Demonstrated opposing aggregation control among DnaJ family members — DNAJA1 knockout reduces polyQ-huntingtin aggregation whereas DNAJB6 knockout increases it.","evidence":"CRISPR knockout, microscopy, filter trap in HEK293","pmids":["32424160"],"confidence":"Medium","gaps":["Mechanism by which DNAJA1 promotes polyQ aggregation unknown","Relevance to neuronal cells untested"]},{"year":2020,"claim":"Mapped a druggable mutant-p53 interaction pocket in the glycine/phenylalanine-rich region, validating it by mutagenesis that disrupts binding and destabilizes mutp53.","evidence":"Homology modeling, mutagenesis, co-IP, virtual screening, in vivo growth assays","pmids":["33208462"],"confidence":"Medium","gaps":["Experimental structure of the pocket lacking","Selectivity over other clients unknown"]},{"year":2021,"claim":"Established client selectivity and downstream consequence: DNAJA1 binds conformational but not DNA-contact or wild-type p53, and its loss reduces CDC42/RAC1 activity, migration, and metastasis.","evidence":"Co-IP selectivity, knockdown, Rho-GTPase and migration assays, xenograft metastasis models in HNSCC","pmids":["34183772"],"confidence":"High","gaps":["Structural basis of conformational-mutant selectivity not defined","Mechanistic link to GTPase activation indirect"]},{"year":2021,"claim":"Identified ubiquitin-mediated control of DNAJA1 abundance by cereblon, with CRBN loss enhancing DNAJA1 chaperone capacity to reduce pathologic tau.","evidence":"Co-IP, CRBN knockout mice, tau aggregation/kinase assays","pmids":["33972400"],"confidence":"Medium","gaps":["DNAJA1 ubiquitination sites not mapped","Whether Hsp70 is co-degraded in cells unresolved"]},{"year":2022,"claim":"Provided high-resolution structural and chemical-biology tools — an NMR J-domain/linker structure with binding sites and small molecules (A11) that bind J-domain residues Y7/K44/Q47 to deplete DNAJA1 and mutp53.","evidence":"NMR, ITC, pull-down/MS, virtual screening, mutagenesis and cell-based depletion/migration assays","pmids":["36291603","36316326"],"confidence":"Medium","gaps":["Full-length structure including substrate-binding domain lacking","On-target selectivity of compounds in vivo unproven"]},{"year":2022,"claim":"Showed conserved pro-aggregation behavior toward amyloid-beta — the ortholog Ydj1 binds Abeta, drives oligomerization, and routes it to mitochondria, with deletion protective.","evidence":"Yeast genetic screen, interaction assays, Drosophila AD model, mitochondrial fractionation","pmids":["36448030"],"confidence":"Medium","gaps":["Direct evidence in mammalian neurons absent","Distinction from tau-clearance role unexplained"]},{"year":2023,"claim":"Established that zinc binding is essential for DNAJA1 structural integrity and chaperone activity, with copper partly substituting.","evidence":"In vitro aggregation assays, metal chelation/reconstitution, yeast complementation, biophysics","pmids":["37244380"],"confidence":"Medium","gaps":["Physiological metal occupancy in cells unknown","Link between metal loss and client release undefined"]},{"year":2024,"claim":"Defined an organismal proteostasis requirement — DNAJA1 knockout reduces testis polyubiquitination and causes complete male infertility with spermatogenesis defects.","evidence":"Knockout mice, Western blot, immunofluorescence, fertility assays","pmids":["39208916"],"confidence":"Medium","gaps":["Specific spermatogenic clients unidentified","Mechanism connecting DNAJA1 to ubiquitination not resolved"]},{"year":2024,"claim":"Linked DNAJA1 to endothelial barrier control, showing its knockout suppresses heat-stroke-induced MLCK-MLC signaling and preserves junctional proteins.","evidence":"Knockout cells/mice, TEER, permeability, proteomics, heat-stroke model","pmids":["38551163"],"confidence":"Medium","gaps":["Direct DNAJA1 target in the MLCK pathway unknown","Whether effect is chaperone-dependent untested"]},{"year":2025,"claim":"Connected DNAJA1 to mitochondrial regulation via a direct PSMD9 interaction through an EXKK motif, with proteasome inhibition enhancing binding and DNAJA1 stability.","evidence":"MS, in vitro binding with purified proteins, mutagenesis, co-IP, mitochondrial membrane potential in MCF7","pmids":["40412052"],"confidence":"Medium","gaps":["Functional consequence of the interaction for proteostasis unclear","How PSMD9 binding affects mitochondrial potential mechanistically unknown"]},{"year":2026,"claim":"Identified YOD1 deubiquitination as a stabilizing input enabling DNAJA1-HSP70 activation of the mitochondrial UPR to limit neuronal apoptosis after subarachnoid hemorrhage.","evidence":"Docking, co-IP, stability assays, YOD1 overexpression in SAH models, mitochondrial assays","pmids":["42103167"],"confidence":"Medium","gaps":["DNAJA1 ubiquitination/deubiquitination sites not mapped","Direct role in UPRmt induction vs correlation unresolved"]},{"year":null,"claim":"It remains unresolved how DNAJA1 achieves client selectivity (e.g., conformational mutant p53 vs others) and how farnesylation, zinc binding, and the J-domain versus C-terminal substrate-binding domain are coordinated to switch between Hsp70-dependent folding and Hsp70-independent functions.","evidence":"No timeline study integrates these determinants into a unified structural mechanism","pmids":[],"confidence":"Low","gaps":["No full-length structure with bound client","No reconstitution dissecting farnesylation/zinc/J-domain contributions to a single client","Substrate-recognition code undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,19]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,10,14,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,13,7]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[5,17]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,8,12]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[3]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[3]},{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[3]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[22,23,27]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,5,10]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,4,23]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,9,17,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10]}],"complexes":[],"partners":["HSPA8","TP53","AICDA","PIWIL1","CDC45","TGM2","PSMD9","CRBN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P31689","full_name":"DnaJ homolog subfamily A member 1","aliases":["DnaJ protein homolog 2","HSDJ","Heat shock 40 kDa protein 4","Heat shock protein J2","HSJ-2","Human DnaJ protein 2","hDj-2"],"length_aa":397,"mass_kda":44.9,"function":"Co-chaperone for HSPA8/Hsc70 (PubMed:10816573). Stimulates ATP hydrolysis, but not the folding of unfolded proteins mediated by HSPA1A (in vitro) (PubMed:24318877). Plays a role in protein transport into mitochondria via its role as co-chaperone. Functions as a co-chaperone for HSPA1B and negatively regulates the translocation of BAX from the cytosol to mitochondria in response to cellular stress, thereby protecting cells against apoptosis (PubMed:14752510). Promotes apoptosis in response to cellular stress mediated by exposure to anisomycin or UV (PubMed:24512202)","subcellular_location":"Membrane; Cytoplasm; Microsome; Nucleus; Cytoplasm, perinuclear region; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P31689/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DNAJA1","classification":"Not Classified","n_dependent_lines":547,"n_total_lines":1208,"dependency_fraction":0.45281456953642385},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000086061","cell_line_id":"CID000011","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"TUBA1B","stoichiometry":10.0},{"gene":"HSPA8","stoichiometry":10.0},{"gene":"TUBB4B","stoichiometry":10.0},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"RNASEH2A","stoichiometry":0.2},{"gene":"NOL11","stoichiometry":0.2},{"gene":"HSPH1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000011","total_profiled":1310},"omim":[{"mim_id":"607207","title":"STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1","url":"https://www.omim.org/entry/607207"},{"mim_id":"606480","title":"ZINC METALLOPROTEINASE STE24; ZMPSTE24","url":"https://www.omim.org/entry/606480"},{"mim_id":"602963","title":"UBIQUITIN-CONJUGATING ENZYME E2 D3; UBE2D3","url":"https://www.omim.org/entry/602963"},{"mim_id":"602837","title":"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1; DNAJA1","url":"https://www.omim.org/entry/602837"},{"mim_id":"602421","title":"CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR","url":"https://www.omim.org/entry/602421"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Microtubules","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DNAJA1"},"hgnc":{"alias_symbol":["HSPF4","hdj-2","dj-2","NEDD7"],"prev_symbol":["HSJ2"]},"alphafold":{"accession":"P31689","domains":[{"cath_id":"1.10.287.110","chopping":"4-72","consensus_level":"high","plddt":85.6041,"start":4,"end":72},{"cath_id":"2.60.260.20","chopping":"101-139_198-246","consensus_level":"medium","plddt":91.5776,"start":101,"end":246},{"cath_id":"-","chopping":"147-187","consensus_level":"medium","plddt":84.5532,"start":147,"end":187},{"cath_id":"2.60.260.20","chopping":"250-326","consensus_level":"high","plddt":93.7869,"start":250,"end":326}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31689","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31689-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31689-F1-predicted_aligned_error_v6.png","plddt_mean":83.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DNAJA1","jax_strain_url":"https://www.jax.org/strain/search?query=DNAJA1"},"sequence":{"accession":"P31689","fasta_url":"https://rest.uniprot.org/uniprotkb/P31689.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31689/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31689"}},"corpus_meta":[{"pmid":"10196362","id":"PMC_10196362","title":"Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10196362","citation_count":377,"is_preprint":false},{"pmid":"10717003","id":"PMC_10717003","title":"Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10717003","citation_count":279,"is_preprint":false},{"pmid":"10075921","id":"PMC_10075921","title":"The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10075921","citation_count":275,"is_preprint":false},{"pmid":"27775703","id":"PMC_27775703","title":"DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.","date":"2016","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27775703","citation_count":209,"is_preprint":false},{"pmid":"25311840","id":"PMC_25311840","title":"Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity.","date":"2014","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/25311840","citation_count":62,"is_preprint":false},{"pmid":"16818651","id":"PMC_16818651","title":"HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16818651","citation_count":56,"is_preprint":false},{"pmid":"31477839","id":"PMC_31477839","title":"KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31477839","citation_count":56,"is_preprint":false},{"pmid":"25253355","id":"PMC_25253355","title":"DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25253355","citation_count":52,"is_preprint":false},{"pmid":"22343013","id":"PMC_22343013","title":"DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.","date":"2012","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22343013","citation_count":51,"is_preprint":false},{"pmid":"24512202","id":"PMC_24512202","title":"Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24512202","citation_count":51,"is_preprint":false},{"pmid":"9168467","id":"PMC_9168467","title":"A role for HDJ-2/HSDJ in correcting subnuclear trafficking, transactivation, and transrepression defects of a glucocorticoid receptor zinc finger mutant.","date":"1997","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/9168467","citation_count":45,"is_preprint":false},{"pmid":"32424160","id":"PMC_32424160","title":"Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32424160","citation_count":44,"is_preprint":false},{"pmid":"20012712","id":"PMC_20012712","title":"Genetic variability and linkage disequilibrium patterns in the bovine DNAJA1 gene.","date":"2010","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/20012712","citation_count":38,"is_preprint":false},{"pmid":"31397499","id":"PMC_31397499","title":"Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.","date":"2019","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31397499","citation_count":37,"is_preprint":false},{"pmid":"34183772","id":"PMC_34183772","title":"DNAJA1 promotes cancer metastasis through interaction with mutant p53.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34183772","citation_count":33,"is_preprint":false},{"pmid":"22085931","id":"PMC_22085931","title":"Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22085931","citation_count":33,"is_preprint":false},{"pmid":"12974469","id":"PMC_12974469","title":"Characterization of two isoforms of a human DnaJ homologue, HSJ2.","date":"2003","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/12974469","citation_count":32,"is_preprint":false},{"pmid":"9839446","id":"PMC_9839446","title":"Characterization of HDJ-2, a human 40 kD heat shock protein.","date":"1998","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9839446","citation_count":31,"is_preprint":false},{"pmid":"32796891","id":"PMC_32796891","title":"Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32796891","citation_count":28,"is_preprint":false},{"pmid":"33208462","id":"PMC_33208462","title":"Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33208462","citation_count":24,"is_preprint":false},{"pmid":"12495215","id":"PMC_12495215","title":"In situ expression of heat shock proteins, Hsc73, Hsj2 and Hsp86 in the developing tooth germ of mouse lower first molar.","date":"2002","source":"The Histochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12495215","citation_count":20,"is_preprint":false},{"pmid":"29331838","id":"PMC_29331838","title":"Association of CAST2, HSP90AA1, DNAJA1 and HSPB1 genes with meat tenderness in Nellore cattle.","date":"2018","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/29331838","citation_count":19,"is_preprint":false},{"pmid":"26959111","id":"PMC_26959111","title":"Knock-down of Hdj2/DNAJA1 co-chaperone results in an unexpected burst of tumorigenicity of C6 glioblastoma cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26959111","citation_count":19,"is_preprint":false},{"pmid":"35586205","id":"PMC_35586205","title":"DNAJA1 Stabilizes EF1A1 to Promote Cell Proliferation and Metastasis of Liver Cancer Mediated by miR-205-5p.","date":"2022","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35586205","citation_count":17,"is_preprint":false},{"pmid":"8623167","id":"PMC_8623167","title":"Increased expression of the HDJ-2 heat shock protein in biopsies of human rejected kidney.","date":"1996","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/8623167","citation_count":17,"is_preprint":false},{"pmid":"9563600","id":"PMC_9563600","title":"Increased expression of HDJ-2 (heat shock protein 40) and heat shock protein 70 in biopsy specimens of transplanted human lungs.","date":"1998","source":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/9563600","citation_count":16,"is_preprint":false},{"pmid":"30349556","id":"PMC_30349556","title":"Environmental Stress Responses of DnaJA1, DnaJB12 and DnaJC8 in Apis cerana cerana.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30349556","citation_count":16,"is_preprint":false},{"pmid":"31076507","id":"PMC_31076507","title":"Heat shock protein DNAJA1 stabilizes PIWI proteins to support regeneration and homeostasis of planarian Schmidtea mediterranea.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31076507","citation_count":15,"is_preprint":false},{"pmid":"11331850","id":"PMC_11331850","title":"Increased expression of HDJ-2 (hsp40) in carotid artery atherosclerosis: a novel heat shock protein associated with luminal stenosis and plaque ulceration.","date":"2001","source":"Journal of vascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/11331850","citation_count":15,"is_preprint":false},{"pmid":"14526221","id":"PMC_14526221","title":"Overexpression of HDJ-2 protects astrocytes from ischemia-like injury and reduces redistribution of ubiquitin staining in vitro.","date":"2003","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14526221","citation_count":14,"is_preprint":false},{"pmid":"15595953","id":"PMC_15595953","title":"Expression of a novel DnaJA1 alternative splicing in human testis and sperm.","date":"2004","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/15595953","citation_count":13,"is_preprint":false},{"pmid":"34264680","id":"PMC_34264680","title":"DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma.","date":"2021","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/34264680","citation_count":11,"is_preprint":false},{"pmid":"36316326","id":"PMC_36316326","title":"DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36316326","citation_count":10,"is_preprint":false},{"pmid":"27551108","id":"PMC_27551108","title":"Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27551108","citation_count":10,"is_preprint":false},{"pmid":"33972400","id":"PMC_33972400","title":"Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33972400","citation_count":10,"is_preprint":false},{"pmid":"34236236","id":"PMC_34236236","title":"High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer.","date":"2021","source":"Biomarkers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34236236","citation_count":9,"is_preprint":false},{"pmid":"22440026","id":"PMC_22440026","title":"Expression of DNAJA1 in bovine muscles according to developmental age and management factors.","date":"2011","source":"Animal : an international journal of animal bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/22440026","citation_count":9,"is_preprint":false},{"pmid":"38309209","id":"PMC_38309209","title":"Novel insights into the post-translational modifications of Ydj1/DNAJA1 co-chaperones.","date":"2023","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/38309209","citation_count":8,"is_preprint":false},{"pmid":"38551163","id":"PMC_38551163","title":"DNAJA1‑knockout alleviates heat stroke‑induced endothelial barrier disruption via improving thermal tolerance and suppressing the MLCK‑MLC signaling pathway.","date":"2024","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/38551163","citation_count":7,"is_preprint":false},{"pmid":"39661355","id":"PMC_39661355","title":"Itaconate Ameliorates Experimental Autoimmune Uveitis by Modulating Teff/Treg Cell Imbalance Via the DNAJA1/CDC45 Axis.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/39661355","citation_count":5,"is_preprint":false},{"pmid":"37977037","id":"PMC_37977037","title":"DNAJA1 promotes proliferation and metastasis of breast cancer by activating mutant P53/NF-κB pathway.","date":"2023","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/37977037","citation_count":5,"is_preprint":false},{"pmid":"35511481","id":"PMC_35511481","title":"BAG1, MGMT, FOXO1, and DNAJA1 as potential drug targets for radiosensitizing cancer cell lines.","date":"2022","source":"International journal of radiation biology","url":"https://pubmed.ncbi.nlm.nih.gov/35511481","citation_count":5,"is_preprint":false},{"pmid":"36448030","id":"PMC_36448030","title":"A pathological role of the Hsp40 protein Ydj1/DnaJA1 in models of Alzheimer's disease.","date":"2022","source":"Cell stress","url":"https://pubmed.ncbi.nlm.nih.gov/36448030","citation_count":5,"is_preprint":false},{"pmid":"39208916","id":"PMC_39208916","title":"DNAJA1 regulates protein ubiquitination and is essential for spermatogenesis in the testes of mice and rats.","date":"2024","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39208916","citation_count":2,"is_preprint":false},{"pmid":"38269516","id":"PMC_38269516","title":"DNAJA1 positively regulates amino acid-stimulated milk protein and fat synthesis in bovine mammary epithelial cells.","date":"2024","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/38269516","citation_count":2,"is_preprint":false},{"pmid":"36291603","id":"PMC_36291603","title":"Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36291603","citation_count":2,"is_preprint":false},{"pmid":"37244380","id":"PMC_37244380","title":"The stability and function of human cochaperone Hsp40/DNAJA1 are affected by zinc removal and partially restored by copper.","date":"2023","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/37244380","citation_count":2,"is_preprint":false},{"pmid":"36220282","id":"PMC_36220282","title":"Druggable sites/pockets of the p53-DNAJA1 protein-protein interaction: In silico modeling and in vitro/in vivo validation.","date":"2022","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/36220282","citation_count":2,"is_preprint":false},{"pmid":"29290829","id":"PMC_29290829","title":"Genetic variation in N- and C-terminal regions of bovine DNAJA1 heat shock protein gene in African, Asian and American cattle.","date":"2018","source":"Journal of genomics","url":"https://pubmed.ncbi.nlm.nih.gov/29290829","citation_count":2,"is_preprint":false},{"pmid":"30972502","id":"PMC_30972502","title":"Truncating biallelic variant in DNAJA1, encoding the co-chaperone Hsp40, is associated with intellectual disability and seizures.","date":"2019","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30972502","citation_count":2,"is_preprint":false},{"pmid":"40412052","id":"PMC_40412052","title":"Novel interaction with PSMD9 regulates DNAJA1 turnover and mitochondrial polarity.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40412052","citation_count":1,"is_preprint":false},{"pmid":"40505999","id":"PMC_40505999","title":"Exploring the obesity-lung inflammation connection: DNAJA1 in focus.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/40505999","citation_count":0,"is_preprint":false},{"pmid":"41222153","id":"PMC_41222153","title":"The Effect and Mechanism of DNAJA1-Mediated Met/Leu Promoting the Proliferation of Bovine Mammary Epithelial Cells.","date":"2025","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41222153","citation_count":0,"is_preprint":false},{"pmid":"42103167","id":"PMC_42103167","title":"YOD1 Regulates Neuronal Mitochondrial Unfolded Protein Response Activation by Deubiquitinating DNAJA1 After Subarachnoid Hemorrhage.","date":"2026","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/42103167","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.10.657506","title":"Decoding Cellular Stress States for Toxicology Using Single-Cell Transcriptomics","date":"2025-06-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.10.657506","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.17.676758","title":"Proteomic and Kinetic Characterization of Prion Seeding in Distinct Human CJD Strains Unveils Early Diagnostic Biomarkers","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.676758","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29752,"output_tokens":7397,"usd":0.100106,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16783,"output_tokens":7392,"usd":0.134357,"stage2_stop_reason":"end_turn"},"total_usd":0.234463,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Hdj-2 (DNAJA1) and Hsc70 form complexes with nascent CFTR at the ER, with complex formation initiated when NBD1 emerges in the cytosol and diminishing after R-domain expression. In experiments with purified components, Hdj-2 and Hsc70 acted synergistically to suppress NBD1 aggregation, suggesting Hdj-2/Hsc70 facilitate early CFTR assembly including formation of an intramolecular NBD1-R-domain complex.\",\n      \"method\": \"Co-immunoprecipitation of CFTR translation intermediates with Hdj-2/Hsc70; in vitro aggregation suppression assay with purified components\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified components plus co-IP of endogenous complexes, multiple orthogonal methods in single study\",\n      \"pmids\": [\"10075921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HDJ-2/HSDJ co-expression significantly suppresses polyglutamine-expanded androgen receptor (ARQ48) aggregate formation in HeLa cells; ARQ48 aggregates co-localize with and sequester HDJ-2/HSDJ, Hsp70, Hsp90, and proteasome PA700 caps but not 20S core particles.\",\n      \"method\": \"Transient transfection in HeLa cells, immunofluorescence, electron microscopy, co-localization studies\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression rescue experiment and co-localization, single lab, two orthogonal methods\",\n      \"pmids\": [\"10196362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HDJ-2/HSDJ overexpression corrects aberrant subnuclear trafficking of a glucocorticoid receptor zinc finger mutant (R496) and restores its transactivation and transrepression activity, demonstrating that the Hsp70/DnaJ chaperone system can act in the nucleus to refold mislocalized/misfolded receptors.\",\n      \"method\": \"Transient transfection in COS-1 cells, immunofluorescence co-localization, transactivation/transrepression reporter assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression rescue with functional readouts, single lab, two orthogonal methods\",\n      \"pmids\": [\"9168467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HDJ-2 (DNAJA1) is farnesylated but not glycosylated, is ubiquitously expressed, localizes throughout the cytoplasm and around the nuclear membrane under basal conditions, and migrates to the Golgi, nucleolus, and nuclear membrane upon heat shock.\",\n      \"method\": \"Immunohistochemistry with polyclonal and monoclonal antibodies, metabolic labeling to determine farnesylation, Western and Northern blot analysis\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical characterization of PTM (farnesylation) plus localization by immunostaining, single lab, two orthogonal methods\",\n      \"pmids\": [\"9839446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Irradiation causes HDJ-2 to migrate from the cytoplasm to the nucleus; this migration is inhibited by farnesyltransferase inhibitor R115777 pre-treatment. Genetic inhibition of HDJ-2 increases radiosensitivity, while overexpression confers radioresistance in glioblastoma cells.\",\n      \"method\": \"Immunofluorescence microscopy for HDJ-2 localization, siRNA knockdown and overexpression with clonogenic survival assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence, loss- and gain-of-function with survival readout, single lab\",\n      \"pmids\": [\"16818651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DNAJA1 stabilizes misfolded/conformational mutant p53 by direct interaction, preventing CHIP ubiquitin ligase-mediated ubiquitylation and proteasomal degradation. Knockdown of DNAJA1 induces CHIP-mediated nuclear export, ubiquitylation, and degradation of mutant p53. Mevalonate-5-phosphate (reduced by statins) is required for this DNAJA1-mutp53 protective interaction.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation, high-throughput statin screening, overexpression rescue experiments in cancer cell lines\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, knockdown and overexpression rescue, pathway epistasis with mevalonate pathway, replicated across multiple methods and cell lines\",\n      \"pmids\": [\"27775703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Farnesylation of DNAJA1 at its C-terminal CAAX motif is required for its ability to bind and stabilize mutant p53. A C394S CAAX-box mutation abolishes DNAJA1 farnesylation and eliminates its capacity to maintain mutant p53 stabilization. Farnesyl pyrophosphate supplementation rescues atorvastatin-induced mutant p53 degradation.\",\n      \"method\": \"Site-directed mutagenesis of DNAJA1 CAAX box, co-immunoprecipitation with anti-DNAJA1/p53 antibodies, farnesyltransferase inhibitor (tipifarnib) treatment, FTase gene knockdown, genetically engineered mouse model\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of functional residue with co-IP validation, pharmacological and genetic inhibition of farnesylation, in vivo mouse model, multiple orthogonal methods\",\n      \"pmids\": [\"31397499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DNAJA1 is a substrate of HDAC6 deacetylase; HDAC6 interacts with DNAJA1 and negatively regulates its acetylation levels. HDAC6-mediated deacetylation modulates the interaction between Hsc70 and DNAJA1.\",\n      \"method\": \"Quantitative proteomics of lysine acetylation in HDAC6 knockout mouse liver, co-immunoprecipitation validation, functional interaction assays in cultured cells\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative proteomics plus co-IP validation, functional consequence on Hsc70-DNAJA1 interaction demonstrated, single lab\",\n      \"pmids\": [\"25311840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DnaJA1 associates with the PB2 and PA subunits of influenza A virus RNA polymerase and enhances viral RNA synthesis in vivo and in vitro. Upon influenza infection, DnaJA1 translocates from cytoplasm to nucleus along with PB1-PA nuclear import. The enhancement of viral RNA synthesis is dependent on DnaJA1's C-terminal substrate-binding domain, not the J-domain (Hsp70-interaction domain).\",\n      \"method\": \"Co-immunoprecipitation, in vitro RNA synthesis assay, immunofluorescence for nuclear translocation, domain deletion/mutation analysis\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro RNA synthesis assay plus co-IP and domain mutagenesis, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"25253355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DnaJA1 overexpression promotes tau clearance via ubiquitin-dependent mechanisms, while DnaJA1 knockdown facilitates tau accumulation. DnaJA1-mediated tau reduction requires lysines known to be poly-ubiquitinated in Alzheimer's brain. Hsp70 co-induction attenuates DnaJA1-driven tau clearance. In vivo, DnaJA1 and tau levels are inversely correlated.\",\n      \"method\": \"Overexpression and siRNA knockdown in cell lines, in vivo correlation studies, ubiquitination site mutant analysis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function with mechanistic follow-up (ubiquitin-dependence), in vivo correlation, single lab, multiple methods\",\n      \"pmids\": [\"22343013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DnaJa1 (but not the paralog DnaJa2) specifically stabilizes activation-induced deaminase (AID), maintaining its protein levels and biological activity. DnaJa1 depletion reduces AID levels, stability, and isotype switching in B cells. DnaJa1-deficient mice show compromised immunization responses and reduced AID protein and isotype switching by ~50%. DnaJa1 farnesylation is required for AID stabilization.\",\n      \"method\": \"Overexpression and siRNA knockdown in cell lines, DnaJa1 knockout mice, farnesyltransferase inhibitor treatment, isotype-switching assays, in vitro interaction studies\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model, loss- and gain-of-function, pharmacological farnesylation inhibition, functional isotype-switching readout, replicated across multiple systems\",\n      \"pmids\": [\"22085931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NMR solution structure of the J-domain of DNAJA1 was solved, identifying a potential DnaK (Hsp70) binding site that overlaps with a predicted inhibitory binding site, suggesting DNAJA1 activity is regulated at this interface. DNAJA1 overexpression suppresses c-Jun hyperphosphorylation and the JNK pathway in pancreatic cancer cells.\",\n      \"method\": \"NMR structure determination, ligand affinity screen, bioinformatics analysis, overexpression in cell lines with JNK pathway readouts\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with bioinformatics and functional overexpression data, single lab, multiple methods but limited mechanistic depth for JNK finding\",\n      \"pmids\": [\"24512202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Two isoforms of HSJ2 (DNAJA1) arise from alternative splicing: HSJ2a (326 aa) localizes to the nucleus when fused to GFP in HeLa cells, while HSJ2b (241 aa, lacking a putative NLS) distributes throughout the cell.\",\n      \"method\": \"GFP-fusion protein expression in HeLa cells, fluorescence microscopy\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct live-cell localization by GFP imaging, single lab, single method, but clear functional consequence of alternative splicing on localization\",\n      \"pmids\": [\"12974469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DNAJA1 is identified as a novel interacting partner and substrate of transglutaminase 2 (TG2). The catalytic core domain of TG2 is essential for interaction. DNAJA1 interacts with the open (active) conformation of TG2 and regulates its transamidation activity in vitro and in situ. DNAJA1 itself serves as a glutamine-donor substrate of TG2.\",\n      \"method\": \"GST pull-down assay, mass spectrometry, ELISA, surface plasmon resonance, domain variant interaction studies, in vitro and in situ transamidation activity assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal binding assays (pulldown, SPR, ELISA) plus enzymatic activity measurement, single lab but rigorous\",\n      \"pmids\": [\"27551108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DNAJA1 physically interacts with PIWI protein SMEDWI-2 in planarian S. mediterranea (validated by yeast two-hybrid and co-IP). DNAJA1 is required for stability of SMEDWI-1 and SMEDWI-2 proteins. Human DNAJA1 similarly binds PIWIL1 and is required for PIWIL1 stability in human gastric cancer cells, demonstrating evolutionary conservation of this chaperone-client relationship.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, RNAi knockdown, protein stability assays in planarian and human cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus knockdown with stability readout, validated in both planarian and human cells, single lab\",\n      \"pmids\": [\"31076507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DNAJA1 is activated transcriptionally by E2F1 and stabilizes CDC45 protein, thereby promoting cell cycle progression in colorectal cancer cells. KNK437 treatment sharply reduces DNAJA1 levels and reverses CDC45 stabilization.\",\n      \"method\": \"siRNA knockdown, overexpression, in vitro and in vivo tumor growth assays, ChIP/reporter assays for E2F1-DNAJA1 transcriptional regulation, western blot for CDC45 protein levels\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined molecular mechanism (E2F1→DNAJA1→CDC45), single lab, multiple cell and animal model validations\",\n      \"pmids\": [\"31477839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In silico homology modeling and site-directed mutagenesis identified a druggable interacting pocket in the DNAJA1 glycine/phenylalanine-rich region critical for interaction with mutant p53 R175H. Mutations in this pocket disrupted DNAJA1-mutp53 interaction and reduced mutp53 stability.\",\n      \"method\": \"3D homology modeling, site-directed mutagenesis, co-immunoprecipitation, virtual drug screening, in vitro and in vivo cancer growth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of interaction interface validated by co-IP with functional consequence, plus computational modeling, single lab\",\n      \"pmids\": [\"33208462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DNAJA1 selectively binds to unfolded (conformational) mutant p53 but not DNA-contact mutant p53, wild-type p53, or p53-null. DNAJA1 knockdown decreases mutp53 levels, reduces filopodia/lamellipodia formation, and decreases active CDC42/RAC1 in HNSCC cells in a mutp53-dependent manner. DNAJA1 knockdown inhibits primary tumor growth and metastasis to lymph nodes and lungs.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation, in vitro migration assays, Rho GTPase activity assays, in vivo xenograft metastasis models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP with selectivity for conformational mutp53, loss-of-function with mechanistic pathway (CDC42/RAC1), in vivo metastasis model, multiple orthogonal methods\",\n      \"pmids\": [\"34183772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cereblon (CRBN), a substrate-recruiting subunit of cullin4-RING-E3-ligase, targets DNAJA1 (DJ2) and Hsp70 for ubiquitin-mediated degradation. CRBN knockout enhances DJ2 chaperone activity, reducing tau phosphorylation and aggregation, improving tau-microtubule association, and reducing accumulation of pathologic tau. DJ2 overexpression prevents tau aggregation induced by okadaic acid and heparin.\",\n      \"method\": \"Co-immunoprecipitation, CRBN knockout mouse model, tau aggregation assays, kinase activity assays (GSK3, ERK, p38), in vivo tau pathology assessment\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus knockout mouse model with functional readouts, single lab, multiple methods\",\n      \"pmids\": [\"33972400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Zinc binding is required for DNAJA1 structural stability and chaperone function (protection of client proteins from aggregation). Zinc removal destabilizes DNAJA1 and impairs its chaperone activity; reintroduction of zinc restores native properties. Copper can partially substitute for zinc in restoring DNAJA1 function.\",\n      \"method\": \"In vitro chaperone activity assay (aggregation suppression), metal chelation and reconstitution, yeast complementation assay (ydj1-deletion strain), biophysical stability measurements\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution and yeast complementation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37244380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DNAJA1 knockout results in a 4-fold decrease in polyglutamine74-huntingtin (polyQ74htt) aggregation in HEK293 cells, opposite to the 5-fold increase seen with DNAJB6 knockout, demonstrating that DNAJA1 and DNAJB6 modulate polyQ aggregation in opposing manners.\",\n      \"method\": \"CRISPR/Cas9 knockout in HEK293 cells, fluorescence microscopy, filter trap assay, cell viability assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR knockout with two orthogonal readouts (microscopy + FTA), single lab\",\n      \"pmids\": [\"32424160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DNAJA1 knockout significantly reduces protein polyubiquitination in mouse testis and results in complete male infertility with spermatogenesis defects. DNAJA1 is co-localized with residual bodies in elongating spermatids, and its expression peaks during postnatal spermatogenesis.\",\n      \"method\": \"DNAJA1 knockout mice, Western blotting, immunofluorescence, fertility assays\",\n      \"journal\": \"Reproductive toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse model with defined cellular phenotype (infertility, reduced polyubiquitination), single lab, two orthogonal methods\",\n      \"pmids\": [\"39208916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PSMD9 directly interacts with DNAJA1 via an EXKK motif. This interaction was confirmed by in vitro binding assays with purified proteins, and mutations in DNAJA1 disrupting the EXKK motif abolished binding. PSMD9 depletion led to elevated mitochondrial membrane potential, linking the PSMD9-DNAJA1 interaction to mitochondrial regulation. Proteasomal inhibition enhanced the PSMD9-DNAJA1 interaction and correlated with increased DNAJA1 stability.\",\n      \"method\": \"Mass spectrometry, in vitro binding assays with purified proteins, site-directed mutagenesis of DNAJA1, co-immunoprecipitation from MCF7 cells, mitochondrial membrane potential measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding assay plus co-IP with mutagenesis validation and functional mitochondrial readout, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"40412052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"YOD1 deubiquitinase stabilizes DNAJA1 through deubiquitination, identified by molecular docking, co-immunoprecipitation, and protein stability assays. Stabilized DNAJA1 binds HSP70 to activate the mitochondrial unfolded protein response (UPRmt), reducing neuronal apoptosis and mitochondrial damage after subarachnoid hemorrhage.\",\n      \"method\": \"Molecular docking, co-immunoprecipitation, protein stability assays, YOD1 overexpression in vivo and in vitro models of SAH, mitochondrial function assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus protein stability and functional rescue assays, in vivo model, single lab, multiple methods\",\n      \"pmids\": [\"42103167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The first 107 amino acid NMR structure of DNAJA1 (J-domain and linker region) was solved, identifying protein and ligand binding sites. Pull-down assays identified 8 novel protein binding partners. NMR and isothermal titration calorimetry confirmed 5 drug-like compounds binding to two distinct sites on DNAJA1.\",\n      \"method\": \"NMR structure determination, virtual drug screening, NMR binding assays, isothermal titration calorimetry, pull-down assay with mass spectrometry\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with ITC binding validation, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"36291603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A compound A11 (analog of virtual-screen hit 7-3) reduces DNAJA1 and conformational mutant p53 levels by binding to the J-domain of DNAJA1 at residues Y7, K44, and Q47. Alanine mutations at these positions prevent A11 binding and render cells insensitive to A11-mediated DNAJA1 and mutp53 depletion and inhibition of cell migration.\",\n      \"method\": \"In silico docking of ~10 million compounds, site-directed mutagenesis, cell-based assays for DNAJA1 and mutp53 levels, migration assays, filopodia formation assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of binding residues validated by functional rescue, combined with virtual screen and cell-based assays, single lab\",\n      \"pmids\": [\"36316326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HDJ-2/HSDJ overexpression increased polyglutamine huntingtin exon 1 inclusion formation in COS-7 cells (a pro-aggregation effect), while having no significant effect on inclusion formation in PC12 and SH-SY5Y cells, demonstrating a cell-type-dependent and potentially aggregation-promoting role for DNAJA1 with mutant huntingtin.\",\n      \"method\": \"Transient transfection in COS-7, PC12, and SH-SY5Y cells, fluorescence microscopy for inclusion counting\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method, cell-type variable results without mechanistic explanation\",\n      \"pmids\": [\"10717003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In yeast and Drosophila models of Alzheimer's disease, the DNAJA1 ortholog Ydj1 physically interacts with amyloid-beta (Abeta) peptides, facilitates Abeta aggregation into small oligomers, and promotes their translocation to mitochondria. Deletion or downregulation of this chaperone protected from Abeta-mediated toxicity.\",\n      \"method\": \"Genetic screen in yeast, molecular interaction assays, Drosophila AD model with knockdown, mitochondrial fractionation\",\n      \"journal\": \"Cell stress\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic screen plus physical interaction and organellar localization studies in two model organisms, single lab\",\n      \"pmids\": [\"36448030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DNAJA1 knockout alleviates heat-stroke-induced endothelial barrier disruption by suppressing the MLCK-MLC signaling pathway and protecting cell junction protein expression (ZO-1, claudin-5, JAM-A, occludin). Proteomic analysis identified 102 proteins activated by heat stroke and inhibited by DNAJA1 knockout, enriched in calcium signaling and vascular-barrier regulation pathways.\",\n      \"method\": \"DNAJA1 knockout cells (lentivirus-mediated) and mice, transepithelial electrical resistance, FITC-Dextran permeability, flow cytometry, western blotting, quantitative proteomics, in vivo heat stroke mouse model\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined pathway (MLCK-MLC) and in vivo validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"38551163\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DNAJA1 is a farnesylated Hsp40/DnaJ co-chaperone that recruits and stimulates Hsc70/Hsp70 ATPase activity via its J-domain, but also acts independently through its C-terminal substrate-binding domain (e.g., to enhance influenza RNA polymerase activity); it stabilizes client proteins including misfolded/conformational mutant p53, AID, PIWI proteins, CDC45, and tau by preventing their proteasomal degradation—a function requiring DNAJA1 farnesylation and regulated by HDAC6-mediated deacetylation, CRBN-mediated ubiquitination, and YOD1-mediated deubiquitination—while its zinc-binding is required for structural integrity and chaperone activity, and its subcellular localization (cytoplasm at rest; nucleus or Golgi upon stress or viral infection) is tightly linked to its diverse cellular functions in proteostasis, cell cycle regulation, DNA damage response, spermatogenesis, and mitochondrial homeostasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DNAJA1 (Hdj-2/HSDJ) is a farnesylated Hsp40/DnaJ co-chaperone that partners with Hsc70/Hsp70 to govern protein quality control across folding, assembly, and stability decisions [#0, #3]. Through its J-domain it recruits and is regulated at the Hsp70 interface, a surface defined structurally by NMR that overlaps a predicted inhibitory site [#11, #24], while its zinc-binding architecture is required for structural integrity and aggregation-suppressing chaperone activity, with copper able to partially substitute for zinc [#19]. Acting with Hsc70, DNAJA1 suppresses aggregation of folding-challenged clients such as nascent CFTR NBD1 and polyglutamine-expanded androgen receptor, and can refold mislocalized nuclear receptors [#0, #1, #2]. A central, recurring activity is the stabilization of specific client proteins against proteasomal degradation: it selectively binds conformational (not DNA-contact or wild-type) mutant p53 to block CHIP-mediated ubiquitylation and degradation, sustaining oncogenic migration, filopodia formation, and metastasis via CDC42/RAC1 [#5, #16, #17], and it likewise stabilizes activation-induced deaminase (AID) to support antibody isotype switching [#10], PIWI proteins including PIWIL1 [#14], and E2F1-induced CDC45 to drive cell-cycle progression [#15]. Stabilization of mutant p53 and AID requires DNAJA1 farnesylation at its C-terminal CAAX motif, linking its function to the mevalonate pathway and rendering it sensitive to statins and farnesyltransferase inhibitors [#5, #6, #10]. DNAJA1 abundance and activity are themselves controlled post-translationally by HDAC6-mediated deacetylation that tunes Hsc70 binding [#7], CRBN-mediated ubiquitin-dependent degradation [#18], and YOD1-mediated deubiquitination [#23]. Its handling of aggregation-prone neuronal substrates is context-dependent — it promotes ubiquitin-dependent tau clearance [#9, #18] yet can favor aggregation of polyglutamine huntingtin and amyloid-beta [#20, #27]. DNAJA1 relocalizes from the cytoplasm to the nucleus, nucleolus, or Golgi upon heat shock, irradiation, or influenza infection, where it independently binds the PB2/PA polymerase subunits to enhance viral RNA synthesis through its C-terminal substrate-binding domain rather than its J-domain [#3, #4, #8]. At the organismal level DNAJA1 supports radioresistance [#4], spermatogenesis and male fertility [#21], and mitochondrial homeostasis, including activation of the mitochondrial unfolded protein response [#22, #23].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that the Hsp70/DnaJ system can act in the nucleus, not just cytoplasm, by showing DNAJA1 overexpression rescues a misfolded glucocorticoid receptor mutant's trafficking and transcriptional function.\",\n      \"evidence\": \"Overexpression rescue with immunofluorescence and reporter assays in COS-1 cells\",\n      \"pmids\": [\"9168467\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding to the receptor not demonstrated\", \"Endogenous-level relevance not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined DNAJA1's basal physical properties and stress behavior — it is farnesylated, ubiquitously expressed, and redistributes to Golgi/nucleolus/nuclear membrane on heat shock — framing localization as a regulated feature.\",\n      \"evidence\": \"Metabolic labeling for farnesylation plus immunostaining and blotting\",\n      \"pmids\": [\"9839446\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of farnesylation not yet defined\", \"Mechanism of stress relocalization unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed DNAJA1 works synergistically with Hsc70 on a physiological folding client (nascent CFTR), suppressing NBD1 aggregation during co-translational assembly, establishing its general aggregation-suppression activity.\",\n      \"evidence\": \"Co-IP of CFTR translation intermediates plus in vitro aggregation assay with purified components\",\n      \"pmids\": [\"10075921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ATPase stimulation kinetics not quantified\", \"In vivo CFTR maturation consequence not measured\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Extended chaperone activity to disease-relevant aggregates, showing DNAJA1 suppresses polyglutamine androgen receptor aggregation and is sequestered into inclusions with Hsp70/Hsp90 and proteasome caps.\",\n      \"evidence\": \"Transfection, immunofluorescence, and EM co-localization in HeLa cells\",\n      \"pmids\": [\"10196362\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect suppression not distinguished\", \"Single overexpression system\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Revealed that DNAJA1's effect on aggregation is substrate- and cell-type-dependent, sometimes promoting rather than suppressing polyglutamine huntingtin inclusions.\",\n      \"evidence\": \"Transfection and inclusion counting across COS-7, PC12, SH-SY5Y cells\",\n      \"pmids\": [\"10717003\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single method without mechanistic explanation\", \"Cell-type variability unexplained\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked alternative splicing to subcellular targeting, showing an NLS-containing isoform localizes to the nucleus while the shorter isoform distributes diffusely.\",\n      \"evidence\": \"GFP-fusion imaging in HeLa cells\",\n      \"pmids\": [\"12974469\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional differences between isoforms not characterized\", \"Endogenous isoform abundance unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected stress-induced nuclear migration to a phenotype, showing irradiation drives farnesylation-dependent nuclear translocation of DNAJA1 and that DNAJA1 levels set radiosensitivity.\",\n      \"evidence\": \"Immunofluorescence, FTase inhibitor, siRNA/overexpression with clonogenic survival in glioblastoma cells\",\n      \"pmids\": [\"16818651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear DNAJA1 substrates after irradiation unknown\", \"Mechanism linking DNAJA1 to DNA damage response undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified the first endogenous client whose stability depends on DNAJA1 — AID — establishing paralog-specific, farnesylation-dependent client stabilization with an immune phenotype.\",\n      \"evidence\": \"Knockdown/overexpression, knockout mice, FTase inhibitor, isotype-switching assays\",\n      \"pmids\": [\"22085931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether stabilization is Hsp70-dependent not resolved\", \"Direct AID-binding interface not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed DNAJA1 promotes ubiquitin-dependent clearance of tau, positioning it in neurodegenerative proteostasis.\",\n      \"evidence\": \"Overexpression/knockdown, ubiquitination-site mutants, in vivo correlation\",\n      \"pmids\": [\"22343013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase mediating tau clearance not identified\", \"Relationship to Hsp70 co-induction antagonism unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined post-translational and structural regulation of DNAJA1 — HDAC6 deacetylation tunes Hsc70 binding, and NMR mapped a J-domain Hsp70/inhibitory interface — and linked DNAJA1 to JNK signaling.\",\n      \"evidence\": \"Acetylome proteomics and co-IP (HDAC6); NMR structure and JNK readouts in cancer cells\",\n      \"pmids\": [\"25311840\", \"24512202\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetylation sites controlling activity not pinpointed\", \"Mechanism of JNK suppression undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established a J-domain-independent function, showing DNAJA1 binds influenza PB2/PA, translocates to the nucleus on infection, and enhances viral RNA synthesis via its C-terminal substrate-binding domain.\",\n      \"evidence\": \"Co-IP, in vitro RNA synthesis assay, domain mutagenesis, immunofluorescence\",\n      \"pmids\": [\"25253355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether enhancement reflects chaperoning of polymerase folding vs direct effect unclear\", \"Hsp70 involvement not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined DNAJA1's most-studied oncogenic client: it directly binds and stabilizes conformational mutant p53 by blocking CHIP-mediated degradation, a function dependent on the mevalonate pathway.\",\n      \"evidence\": \"Reciprocal co-IP, knockdown/rescue, statin screen in cancer lines\",\n      \"pmids\": [\"27775703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise binding interface not yet mapped at this stage\", \"Generality across mutp53 alleles untested here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified DNAJA1 as an interactor, regulator, and glutamine-donor substrate of transglutaminase 2, coupling it to TG2 conformational/activity control.\",\n      \"evidence\": \"GST pull-down, MS, ELISA, SPR, transamidation assays\",\n      \"pmids\": [\"27551108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequence of TG2 modification of DNAJA1 unknown\", \"Physiological context of this interaction undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mechanistically tied DNAJA1's client-stabilizing function to its lipid modification, showing CAAX-motif farnesylation is required to bind and protect mutant p53.\",\n      \"evidence\": \"CAAX mutagenesis, co-IP, FTase inhibitor and knockdown, mouse model\",\n      \"pmids\": [\"31397499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How farnesylation enables client binding mechanistically unclear\", \"Membrane vs soluble pool contributions unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded the client repertoire to germline and cell-cycle proteins — DNAJA1 stabilizes conserved PIWI proteins (PIWIL1) and E2F1-induced CDC45 to drive proliferation.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, knockdown, stability assays in planarian/human cells (PIWI); ChIP/reporter and stability assays in colorectal cells (CDC45)\",\n      \"pmids\": [\"31076507\", \"31477839\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether stabilization is direct chaperoning or indirect not fully resolved\", \"Hsp70 dependence not established for these clients\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated opposing aggregation control among DnaJ family members — DNAJA1 knockout reduces polyQ-huntingtin aggregation whereas DNAJB6 knockout increases it.\",\n      \"evidence\": \"CRISPR knockout, microscopy, filter trap in HEK293\",\n      \"pmids\": [\"32424160\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which DNAJA1 promotes polyQ aggregation unknown\", \"Relevance to neuronal cells untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapped a druggable mutant-p53 interaction pocket in the glycine/phenylalanine-rich region, validating it by mutagenesis that disrupts binding and destabilizes mutp53.\",\n      \"evidence\": \"Homology modeling, mutagenesis, co-IP, virtual screening, in vivo growth assays\",\n      \"pmids\": [\"33208462\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Experimental structure of the pocket lacking\", \"Selectivity over other clients unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established client selectivity and downstream consequence: DNAJA1 binds conformational but not DNA-contact or wild-type p53, and its loss reduces CDC42/RAC1 activity, migration, and metastasis.\",\n      \"evidence\": \"Co-IP selectivity, knockdown, Rho-GTPase and migration assays, xenograft metastasis models in HNSCC\",\n      \"pmids\": [\"34183772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of conformational-mutant selectivity not defined\", \"Mechanistic link to GTPase activation indirect\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified ubiquitin-mediated control of DNAJA1 abundance by cereblon, with CRBN loss enhancing DNAJA1 chaperone capacity to reduce pathologic tau.\",\n      \"evidence\": \"Co-IP, CRBN knockout mice, tau aggregation/kinase assays\",\n      \"pmids\": [\"33972400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNAJA1 ubiquitination sites not mapped\", \"Whether Hsp70 is co-degraded in cells unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided high-resolution structural and chemical-biology tools — an NMR J-domain/linker structure with binding sites and small molecules (A11) that bind J-domain residues Y7/K44/Q47 to deplete DNAJA1 and mutp53.\",\n      \"evidence\": \"NMR, ITC, pull-down/MS, virtual screening, mutagenesis and cell-based depletion/migration assays\",\n      \"pmids\": [\"36291603\", \"36316326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full-length structure including substrate-binding domain lacking\", \"On-target selectivity of compounds in vivo unproven\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed conserved pro-aggregation behavior toward amyloid-beta — the ortholog Ydj1 binds Abeta, drives oligomerization, and routes it to mitochondria, with deletion protective.\",\n      \"evidence\": \"Yeast genetic screen, interaction assays, Drosophila AD model, mitochondrial fractionation\",\n      \"pmids\": [\"36448030\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct evidence in mammalian neurons absent\", \"Distinction from tau-clearance role unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established that zinc binding is essential for DNAJA1 structural integrity and chaperone activity, with copper partly substituting.\",\n      \"evidence\": \"In vitro aggregation assays, metal chelation/reconstitution, yeast complementation, biophysics\",\n      \"pmids\": [\"37244380\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological metal occupancy in cells unknown\", \"Link between metal loss and client release undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined an organismal proteostasis requirement — DNAJA1 knockout reduces testis polyubiquitination and causes complete male infertility with spermatogenesis defects.\",\n      \"evidence\": \"Knockout mice, Western blot, immunofluorescence, fertility assays\",\n      \"pmids\": [\"39208916\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific spermatogenic clients unidentified\", \"Mechanism connecting DNAJA1 to ubiquitination not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked DNAJA1 to endothelial barrier control, showing its knockout suppresses heat-stroke-induced MLCK-MLC signaling and preserves junctional proteins.\",\n      \"evidence\": \"Knockout cells/mice, TEER, permeability, proteomics, heat-stroke model\",\n      \"pmids\": [\"38551163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DNAJA1 target in the MLCK pathway unknown\", \"Whether effect is chaperone-dependent untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected DNAJA1 to mitochondrial regulation via a direct PSMD9 interaction through an EXKK motif, with proteasome inhibition enhancing binding and DNAJA1 stability.\",\n      \"evidence\": \"MS, in vitro binding with purified proteins, mutagenesis, co-IP, mitochondrial membrane potential in MCF7\",\n      \"pmids\": [\"40412052\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the interaction for proteostasis unclear\", \"How PSMD9 binding affects mitochondrial potential mechanistically unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified YOD1 deubiquitination as a stabilizing input enabling DNAJA1-HSP70 activation of the mitochondrial UPR to limit neuronal apoptosis after subarachnoid hemorrhage.\",\n      \"evidence\": \"Docking, co-IP, stability assays, YOD1 overexpression in SAH models, mitochondrial assays\",\n      \"pmids\": [\"42103167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNAJA1 ubiquitination/deubiquitination sites not mapped\", \"Direct role in UPRmt induction vs correlation unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how DNAJA1 achieves client selectivity (e.g., conformational mutant p53 vs others) and how farnesylation, zinc binding, and the J-domain versus C-terminal substrate-binding domain are coordinated to switch between Hsp70-dependent folding and Hsp70-independent functions.\",\n      \"evidence\": \"No timeline study integrates these determinants into a unified structural mechanism\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length structure with bound client\", \"No reconstitution dissecting farnesylation/zinc/J-domain contributions to a single client\", \"Substrate-recognition code undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 19]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 10, 14, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 13, 7]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [5, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 8, 12]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [22, 23, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 5, 10]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 4, 23]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 9, 17, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HSPA8\", \"TP53\", \"AICDA\", \"PIWIL1\", \"CDC45\", \"TGM2\", \"PSMD9\", \"CRBN\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":9,"faith_total":9,"faith_pct":100.0}}